Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Income from Non-Controlling Interests (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Income from Non-Controlling Interests for 11 consecutive years, with -$1.6 million as the latest value for Q3 2025.

  • Quarterly Income from Non-Controlling Interests fell 55.82% to -$1.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$4.1 million through Dec 2025, up 3.23% year-over-year, with the annual reading at -$4.1 million for FY2025, 3.23% up from the prior year.
  • Income from Non-Controlling Interests hit -$1.6 million in Q3 2025 for vTv Therapeutics, down from -$1.3 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of -$233000.0 in Q2 2021 to a low of -$2.4 million in Q4 2021.
  • Historically, Income from Non-Controlling Interests has averaged -$1.3 million across 5 years, with a median of -$1.2 million in 2024.
  • Biggest YoY gain for Income from Non-Controlling Interests was 85.64% in 2021; the steepest drop was 605.61% in 2021.
  • Year by year, Income from Non-Controlling Interests stood at -$2.4 million in 2021, then surged by 44.7% to -$1.3 million in 2022, then rose by 28.4% to -$963000.0 in 2023, then grew by 16.61% to -$803000.0 in 2024, then plummeted by 105.11% to -$1.6 million in 2025.
  • Business Quant data shows Income from Non-Controlling Interests for VTVT at -$1.6 million in Q3 2025, -$1.3 million in Q2 2025, and -$1.1 million in Q1 2025.